Archives
- 2026-11
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
6-OHDA Hydrochloride: Cell Assay Workflows
2026-09-27
Use 6-OHDA hydrochloride to build a controlled cell-based model of catecholaminergic injury, with a dose–time pilot that separates acute exposure from later cell damage. The workflow also explains how to interpret the cited macrophage study without mistaking its tumor-immunity findings for evidence about 6-OHDA.
Lovastatin for More Reliable Cell Assays
2026-09-26
Learn how to design and interpret cell viability, proliferation, and cytotoxicity experiments with Lovastatin (SKU A4365). This scenario-driven guide connects reported potency and solubility data with practical controls, stock handling, and product-selection considerations.
RepSox ALK5 Inhibitor for iPSC Research
2026-09-25
RepSox offers a controllable way to test ALK5 inhibition in stem-cell workflows, including exploratory studies of megakaryocyte and platelet differentiation. A 2026 hiPSC study provides a useful process benchmark—but did not test RepSox, so its results should guide assay design rather than be attributed to this compound.
Etoposide (VP-16): Practical DNA Damage Workflows
2026-09-25
Use Etoposide (VP-16) to connect topoisomerase II inhibition with DNA double-strand breaks and apoptosis in cancer models. This guide pairs cell-line-aware dose finding with assay design, practical handling advice, and troubleshooting for more interpretable results.
Amphotericin B: Mechanism and Research Use
2026-09-24
Amphotericin B is a polyene antifungal antibiotic used in research on fungal membrane integrity and antifungal activity. This overview explains its sterol-dependent mechanism, product-reported benchmarks, and limits when interpreting Candida biofilm or prion-model findings.
6-OHDA Hydrochloride: Evidence and Use Boundaries
2026-09-24
6-OHDA hydrochloride is a catecholaminergic neurotoxin used to create experimental lesions in Parkinsonian research models. Its established rationale is distinct from the 25-hydroxycholesterol macrophage pathway described in the supplied Immunity study; the available product dossier does not provide a product-specific protocol.
NF-κB–YAP Control of Pyroptosis in Ulcerative Colitis
2026-09-23
A 2026 study links NF-κB p65 activation to LATS1-associated YAP inactivation and increased NLRP3 expression, connecting inflammatory signaling with pyroptosis in ulcerative colitis models. Its cell and mouse experiments suggest that YAP can restrain epithelial pyroptosis, while GSDMD-dependent cell death contributes to colitis severity.
A40926 Production Tools in Nonomuraea
2026-09-23
Yushchuk and colleagues developed promoter-reporter tools for genetically recalcitrant Nonomuraea species and used them to identify regulatory strategies for improving A40926 biosynthesis. Overexpression of pathway-specific positive regulators increased production, providing a knowledge-based route to strain improvement and a foundation for future glycopeptide engineering.
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-22
The reference study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1, rather than stabilizing or folding the enzyme. These findings establish mitochondrial proteostasis as a post-translational regulator of TCA-cycle activity and carbohydrate catabolism, with implications for interpreting metabolic phenotypes in cells and mice.
Ertugliflozin Beyond Glucose: A Translational Playbook
2026-09-22
Ertugliflozin (PF-04971729) illustrates why target selectivity is only the starting point for translational research. This thought-leadership guide connects renal glucose transport, comparative cardioprotection, assay design, and ulcerative colitis research into a practical framework for interpreting mechanism, exposure, and disease-context effects.
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-09-21
A 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that selectively binds native OGDH and promotes its reduction through HSPA9 and LONP1. The work expands the role of mitochondrial proteostasis from protein folding to targeted control of a rate-limiting metabolic enzyme, with consequences for OGDH complex activity and carbohydrate catabolism.
HOBt in Route Design: From Coupling to SAR
2026-09-21
HOBt (1-Hydroxybenzotriazole) is more than a peptide-coupling additive: it can shape stereochemical control and route reliability in medicinal chemistry. This article examines its mechanism through an indazole glucagon receptor antagonist synthesis and translates the evidence into practical workflow decisions.
Bestatin as a Chemical Probe of Jasmonate Signaling
2026-09-20
The reference study established bestatin as a chemical-genetic probe for jasmonic acid signaling in Arabidopsis and tomato, rather than merely an aminopeptidase inhibitor. By combining gene-expression analysis, pathway mutants, developmental phenotyping, and resistant-mutant screening, the authors identified distinct genetic classes that help separate jasmonate perception, response, and bestatin-specific effects.
Tetracycline C6589 for Reliable Cell Assays
2026-09-19
Learn how Tetracycline (SKU C6589) can be incorporated into cell viability, proliferation, and cytotoxicity workflows without confusing antibiotic selection effects with biological endpoints. This scenario-based guide covers mechanism, assay controls, DMSO preparation, interpretation, and evidence-based product selection.
PTX3–TLR4/NF-κB–FGF21 Axis in Glucocorticoid ONFH
2026-09-18
The reference study identifies PTX3 as a protective regulator of glucocorticoid-induced osteonecrosis of the femoral head and places it upstream of a TLR4/NF-κB/FGF21 signaling axis. Its combination of patient samples, cellular models, knockout mice, recombinant protein rescue, and pathway blockade provides a mechanistic framework for studying impaired osteogenesis and apoptosis in ONFH.